Valuation and Earnings
This table compares Clover Leaf Capital and its competitors gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Clover Leaf Capital | N/A | -$1.05 million | -54.35 |
Clover Leaf Capital Competitors | $4.23 billion | $97.61 million | -14.24 |
Clover Leaf Capital’s competitors have higher revenue and earnings than Clover Leaf Capital. Clover Leaf Capital is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Risk and Volatility
Clover Leaf Capital has a beta of 0.07, indicating that its share price is 93% less volatile than the S&P 500. Comparatively, Clover Leaf Capital’s competitors have a beta of 1.01, indicating that their average share price is 1% more volatile than the S&P 500.
Insider and Institutional Ownership
Profitability
This table compares Clover Leaf Capital and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Clover Leaf Capital | N/A | N/A | -9.57% |
Clover Leaf Capital Competitors | -122.79% | -53.82% | -23.42% |
Summary
Clover Leaf Capital competitors beat Clover Leaf Capital on 5 of the 9 factors compared.
About Clover Leaf Capital
Clover Leaf Capital Corp. does not have significant operations. The company focuses on effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization, and other business combination with one or more businesses. It intends to acquire companies operating in the cannabis industry. The company was incorporated in 2021 and is based in Miami, Florida.
Receive News & Ratings for Clover Leaf Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Leaf Capital and related companies with MarketBeat.com's FREE daily email newsletter.